Olympus upgrades guidance following better-than-expected report

Japanese Olympus has closed this year's Q1 so well that the medtech firm, whose advisors include former Ambu CEO Lars Marcher, upgrades its guidance for the whole year.
Photo: Yuriko Nakao/Reuters/Ritzau Scanpix
Photo: Yuriko Nakao/Reuters/Ritzau Scanpix

Thursday morning, Japanese medical equipment manufacturer Olympus presented its first quarter financial result, which shows better sales than expected, which is also demonstrated in the firm's operating earnings.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading